Peter Kreutzmann

Title: **Peter Kreutzmann: Innovator in Serine Proteinase Inhibitors**

Introduction

Peter Kreutzmann, located in Magdeburg, Germany, is a notable inventor who has made significant contributions in the field of biochemistry. With a focus on serine proteinase inhibitors, Kreutzmann's innovative approach holds promise for advancements in medical and therapeutic applications.

Latest Patents

Peter Kreutzmann is recognized for his patent related to serine proteinase inhibitors. The patent details inhibitors characterized by the amino acid sequence in accordance with Seq. ID No. 1. This invention could potentially enhance the understanding and treatment of various conditions influenced by serine proteases.

Career Highlights

Kreutzmann works with Pharis Biotec GmbH, a company dedicated to biotechnological advancements. His work at this organization signifies a commitment to pushing the boundaries of scientific research and innovation in the biotech industry.

Collaborations

Throughout his career, Kreutzmann has collaborated with esteemed colleagues, including Wolf-Georg Forssmann and Hans-Jürgen Mägert. These partnerships highlight the collaborative spirit prevalent in the field of biotechnology, enhancing the potential for groundbreaking discoveries.

Conclusion

Peter Kreutzmann exemplifies the dedication and creativity of inventors who strive to make a positive impact through their innovations. His patent on serine proteinase inhibitors stands as a testament to his contributions to science and his commitment to advancing medical knowledge.